M&A / Deals Sun sets out $11.75bn takeover play for Organon PharmaphorumAfter downplaying persistent rumours for months, Sun Pharma has broken cover with an $11.75 billion takeover agreement for Organon.Read full story pharminent April 27, 2026 (Last updated: April 27, 2026) Pharmaphorum After downplaying persistent rumours for months, Sun Pharma has broken cover with an $11.75 billion takeover agreement for Organon. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Gene therapy leaders aim to help more Baby KJs with novel regulatory modelsNext: Sun Pharma to acquire Organon for $11.75bn Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
